BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory

Qubit Pharmaceuticals

Qubit Pharmaceuticals logo

Founded
2020
Patents
2
Publications
3

Technologies

AI Companies (Drug Discovery)

Qubit Pharmaceuticals is a brand-new international company, spun off from CNAM, CNRS, University of Texas at Austin, Sorbonne University and Washington University, and based in Paris. Qubit Pharmaceuticals builds upon more than 20 years of R&D awarded by the most prestigious prizes.
Qubit Pharmaceuticals is supported by Quantonation, a leading investment fund in quantum technologies in its mission to revolutionize the way drugs are developed and provide safer and more efficient drugs faster.
Qubit Pharmaceuticals is laureate of the EIT health headstart program and incubated at Paris Biotech Santé.

Quantum biomodeling


Posts Mentioning This Company

From Qubits to Cures: The Promise of Quantum Computing in Pharmaceutical Research and Development (a Realistic View)

  
In a recent announcement, Moderna and IBM unveiled their partnership aimed at utilizing cutting-edge technologies, such as artificial intelligence (AI) and quantum computing, to accelerate research in messenger RNA (mRNA) therapeutics and vaccines. This collaboration highlights the growing interest in the potential of quantum computing within the life sciences sector.